Product References
miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC.
Cancers
Shibata T,Cao DY,Dar TB,Ahmed F,Bhat SA,Veiras LC,Bernstein EA,Khan AA,Chaum M,Shiao SL,Tourtellotte WG,Giani JF,Bernstein KE,Cui X,Vail E,Khan Z
PA5-68552 was used in Western Blotting to demonstrate a novel miR124-3p- and miR766-3p-based biological mechanism governing treatment-resistant HNSCC, which can be targeted to improve clinical outcomes in HNSCC.
Thu Oct 27 00:00:00 EDT 2022
miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC.
Cancers
Shibata T,Cao DY,Dar TB,Ahmed F,Bhat SA,Veiras LC,Bernstein EA,Khan AA,Chaum M,Shiao SL,Tourtellotte WG,Giani JF,Bernstein KE,Cui X,Vail E,Khan Z
PA5-68552 was used in Western Blotting to demonstrate a novel miR124-3p- and miR766-3p-based biological mechanism governing treatment-resistant HNSCC, which can be targeted to improve clinical outcomes in HNSCC.
Thu Oct 27 00:00:00 EDT 2022
miR766-3p and miR124-3p Dictate Drug Resistance and Clinical Outcome in HNSCC.
Cancers
Shibata T,Cao DY,Dar TB,Ahmed F,Bhat SA,Veiras LC,Bernstein EA,Khan AA,Chaum M,Shiao SL,Tourtellotte WG,Giani JF,Bernstein KE,Cui X,Vail E,Khan Z
PA5-68552 was used in Western Blotting to demonstrate a novel miR124-3p- and miR766-3p-based biological mechanism governing treatment-resistant HNSCC, which can be targeted to improve clinical outcomes in HNSCC.
Thu Oct 27 00:00:00 EDT 2022
Generation of a genetically modified pig model with CREBRFR457Q variant.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology
Li Y,Wang H,Chen H,Liao Y,Gou S,Yan Q,Zhuang Z,Li H,Wang J,Suo Y,Lan T,Liu Y,Zhao Y,Zou Q,Nie T,Hui X,Lai L,Wu D,Fan N
PA5-68552 was used in Western Blotting to investigate the functional consequences of the CREBRF variant by introducing the corresponding human mutation R457Q into the porcine genome.
Tue Nov 01 00:00:00 EDT 2022